RINVOQ is now approved as the first and only oral JAK inhibitor for adults with active non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is the first and only JAK inhibitor approved for both active ankylosing spondylitis (AS) and nr-axSpA1-3 In a clinical study, RINVOQ delivered…
Related Posts
Destination: Discovery
Luxury Portfolio International® Explores Bucket List-Worthy Travel and Must-see Global Hot Spots in Just-released Bi-Annual Magazine Additional topics include what’s trending in architecture and home design, a profile on the influence of Indian cuisine, and a rundown of top luxury gadgets…
KAYAK te invita a descubrir el mundo Cumbiana II de Carlos Vives Viaja con el corazón lleno de música y explora grandes destinos.
Carlos Vives regresa con su nuevo álbum Cumbiana II, que demuestra que estamos #UnidosEnLaDiversidad. Viaja con el corazón lleno de música y explora grandes destinos. CIUDAD DE MÉXICO, 2 de junio de 2022 /PRNewswire/ — A través del viaje que propone KAYAK por el universo de Cumbiana II,…
National Park Foundation and Helmsley Charitable Trust Continue to Enhance the Visitor Experience at Parks, Focusing Now on Bering Land Bridge National Preserve in Alaska
WASHINGTON, Aug. 11, 2022 /PRNewswire/ — The National Park Foundation is excited to announce a lead grant for the collective effort to improve the visitor experience at Bering Land Bridge National Preserve, thanks to the generous support of The Leona M. and Harry B. Helmsley Charitable…